This report canvasses the extraordinary recent developments in genome sequencing and genetic engineering, which will transform all biological enterprises, including healthcare, among the most important parts of the global economy. It argues that there is a opportunity for Australia to play a leading role in a major economic and revolution with digital deliverables, capitalising on...

Policy should reflect a society’s ethical positions on issues, and too often the two are divorced until a conflict arises. As such, the tools in this document are presented as a starting point to develop or refine a set of guiding principles and ethical standards, as you craft or revise genomic data policy and regulation...

This guidance document offers a collection of case studies and set of questions to prompt deeper discussions about ethical tensions pertinent to the collection and use of genomic data.

This paper discusses why this is a particular moment for the NHS and Genomics England (GE), as they structure the commercial relationships with companies accessing the 100K Genomes database.

This article argues that while some genetically targeted tests and interventions have demonstrated potential for population‐scale health benefits, more evidence of the cost‐effectiveness is needed.